Available Trials

Anal Cancer

  • STAR 18134

    Locally advanced or metastatic Squamous Carcinoma of the Anal Canal

    Available at 4 locations

Breast Cancer

  • STAR14059

    HER2 Amplified Metastatic Breast Cancer

    Available at 8 locations

  • USOR18109

    All Pathologies/Patients

    Available at 7 locations

  • USOR17079

    Clinical Data to Evaluate New Gene Expression Profiles (A Registry), All Comers Applicable

    Available at 7 locations

  • USOR 17009

    HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer (ER+/PR+/HER2- )

    Available at 7 locations

  • USOR 16128

    ER+/HER2- Breast Cancer

    Available at 7 locations

Endometrial Cancer

  • USOR 17197

    Advanced Endometrial Cancer

    Available at 7 locations

Gastric

  • STAR 18016

    Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

    Available at 8 locations

Head and Neck

Leukemia

Lung Cancer

  • STAR 18164

    Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors with RET fusion

    Available at 8 locations

  • STAR 18129

    Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer

    Available at 8 locations

  • STAR 18076

    Stage IIIB (locally advanced or recurrent and not a candidate for curative therapy) or stage IV Advanced Non–Small-Cell Lung Cancer

    Available at 8 locations

  • STAR 17143

    Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation

    Available at 8 locations

  • USOR18109

    All Pathologies/Patients

    Available at 7 locations

  • USOR 17199

    Metastatic Non-Small Cell Lung Cancer Expressing High Levels of PD-L1

    Available at 7 locations

Lymphoma

  • USOR18109

    All Pathologies/Patients

    Available at 7 locations

  • STAR 16248

    Follicular Lymphoma with EZH2 mutation

    Available at 8 locations

  • STAR 11282

    Hodkin Lymphoma (HL) in Adults Age 60 and Above

    Available at 8 locations

  • USOR 16065

    Follicular Lymphoma, Non-Hodgkin’s Lymphoma, Mantle Cell Lymphoma

    Available at 7 locations

Multiple Myeloma

Myelofibrosis

  • STAR 17085

    Myelofibrosis, post-poycythemia vera myelofibrosis, post essential thrombocytopenia myelo fibrosis

    Available at 8 locations

Neutropenia

  • USOR18109

    All Pathologies/Patients

    Available at 7 locations

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer

  • STAR 16238

    Metastatic Castration-resistant Prostate Cancer (mCRPC) with BRCA1/2 mutation or ATM

    Available at 8 locations

  • USOR 18128

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    Available at 8 locations

  • USOR18109

    All Pathologies/Patients

    Available at 7 locations

  • STAR 16237

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    Available at 8 locations

Renal Cancer

  • USOR 16145

    Clear Renal Cell Carcinoma

    Available at 7 locations

Skin Cancer

Solid Tumors

  • STAR 18164

    Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors with RET fusion

    Available at 8 locations

  • STAR 16248

    Follicular Lymphoma with EZH2 mutation

    Available at 8 locations

Rare Malignancies

Urothelial Cancer

  • USOR 18283

    urothelial or non-urothelial carcinoma of the urinary tract

    Available at 7 locations

  • STAR 15228

    Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

    Available at 8 locations